Critical Care

official impact factor 4.60
Search for
Advanced search
Critical Care
Tools
Correction

The role of corticosteroids in severe community-acquired pneumonia: a systematic review

Jorge IF Salluh1,2*, Pedro Póvoa3, Márcio Soares1, Hugo C Castro-Faria-Neto2, Fernando A Bozza4 and Patrícia T Bozza2

Author Affiliations

1 Intensive Care Unit, Instituto Nacional de Câncer, Praça Cruz Vermelha, 23, 10 andar – Centro, Rio de Janeiro-RJ, Brazil 20230-130

2 Immunopharmacology Laboratory, Instituto Oswaldo Cruz, FIOCRUZ, Av. Brasil, 4365, Rio de Janeiro-RJ, Brazil 21045-900

3 Medical Intensive Care Unit, Hospital de São Francisco Xavier. Centro Hospitalar de Lisboa Ocidental, Estrada do Forte do Alto do Duque, CEP 1449-005 Lisboa, Portugal

4 Instituto de Pesquisa Clínica Evandro Chagas, Fundação Oswaldo Cruz, Av. Brasil, 4365, Rio de Janeiro-RJ, Brazil 21045-900

For all author emails, please log on.

Critical Care 2008, 12:434 doi:10.1186/cc7107


The electronic version of this article is the complete one and can be found online at: http://ccforum.com/content/12/6/434


Published:7 November 2008

© 2008 BioMed Central Ltd

Correction

Following the publication of the above article [1], we noticed that in Table 1, concerning the data of the study from Garcia-Vidal the dose of methylprednisolone is not 14.5 mg/day but 45 mg/day.

Table 1. Recent literature on the role of corticosteroids in severe community-acquired pneumonia

Competing interests

The authors declare that they have no competing interests.

References

  1. Salluh JI, Povoa P, Soares M, Castro-Faria-Neto HC, Bozza FA, Bozza PT: The role of corticosteroids in severe community-acquired pneumonia: a systematic review.

    Crit Care 2008, 12:R76. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text OpenURL